| 000 | 01796 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517111518.0 | ||
| 264 | 0 | _c20170616 | |
| 008 | 201706s 0 0 eng d | ||
| 022 | _a1471-4159 | ||
| 024 | 7 |
_a10.1111/jnc.13770 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSmith, Amena W | |
| 245 | 0 | 0 |
_aCalpain inhibition reduces structural and functional impairment of retinal ganglion cells in experimental optic neuritis. _h[electronic resource] |
| 260 |
_bJournal of neurochemistry _c10 2016 |
||
| 300 |
_a270-284 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCalpain _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aCarbamates _xpharmacology |
| 650 | 0 | 4 |
_aCell Death _xdrug effects |
| 650 | 0 | 4 |
_aElectroretinography _xdrug effects |
| 650 | 0 | 4 |
_aEncephalomyelitis, Autoimmune, Experimental _xdrug therapy |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aGliosis _xprevention & control |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMyelin Basic Protein _xmetabolism |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
| 650 | 0 | 4 |
_aNystagmus, Optokinetic _xdrug effects |
| 650 | 0 | 4 |
_aOptic Neuritis _xdrug therapy |
| 650 | 0 | 4 | _aPhotic Stimulation |
| 650 | 0 | 4 |
_aRetinal Ganglion Cells _xdrug effects |
| 650 | 0 | 4 |
_aVisual Acuity _xdrug effects |
| 700 | 1 | _aRohrer, Baerbel | |
| 700 | 1 | _aWheless, Lee | |
| 700 | 1 | _aSamantaray, Supriti | |
| 700 | 1 | _aRay, Swapan K | |
| 700 | 1 | _aInoue, Jun | |
| 700 | 1 | _aAzuma, Mitsuyoshi | |
| 700 | 1 | _aBanik, Naren L | |
| 773 | 0 |
_tJournal of neurochemistry _gvol. 139 _gno. 2 _gp. 270-284 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/jnc.13770 _zAvailable from publisher's website |
| 999 |
_c26318314 _d26318314 |
||